Literature DB >> 27633572

Bilateral renal tumors in an adult man with Smith-Magenis syndrome: The role of the FLCN gene.

Leila Dardour1, Pieter Verleyen2, Karl Lesage2, Maureen Holvoet3, Koen Devriendt4.   

Abstract

Smith-Magenis syndrome (SMS) is a contiguous-gene disorder most commonly caused by a deletion of chromosome 17p11.2. We report a 57 year-old man with SMS who presents bilateral renal tumors. This is most likely related to haploinsufficiency of FLCN gene, located in the deleted region, and a known tumor suppressor gene. Haploinsufficiency of FLCN causes Birt-Hogg-Dubé syndrome (BHDS), characterized by pulmonary cysts, renal and skin tumors. The present observation suggests that the follow-up of patients with SMS should also focus on possible manifestations of BHDS.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27633572     DOI: 10.1016/j.ejmg.2016.09.005

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  4 in total

1.  Birt-Hogg-Dubé symptoms in Smith-Magenis syndrome include pediatric-onset pneumothorax.

Authors:  Brenda Finucane; Juliann M Savatt; Hermela Shimelis; Santhosh Girirajan; Scott M Myers
Journal:  Am J Med Genet A       Date:  2021-03-05       Impact factor: 2.578

Review 2.  RAI1 gene mutations: mechanisms of Smith-Magenis syndrome.

Authors:  Mariateresa Falco; Sonia Amabile; Fabio Acquaviva
Journal:  Appl Clin Genet       Date:  2017-11-03

Review 3.  Smith-Magenis Syndrome-Clinical Review, Biological Background and Related Disorders.

Authors:  Berardo Rinaldi; Roberta Villa; Alessandra Sironi; Livia Garavelli; Palma Finelli; Maria Francesca Bedeschi
Journal:  Genes (Basel)       Date:  2022-02-11       Impact factor: 4.096

4.  Copy number variations of chromosome 17p11.2 region in children with development delay and in fetuses with abnormal imaging findings.

Authors:  Yuanyuan Zhang; Xiaoliang Liu; Haiming Gao; Rong He; Guoming Chu; Yanyan Zhao
Journal:  BMC Med Genomics       Date:  2021-09-01       Impact factor: 3.063

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.